| Dec'19 | Sep'19 | Jun'19 | Mar'19 | Dec'18 | Sep'18 | Jun'18 | Mar'18 | Dec'17 | Sep'17 | Jun'17 | Mar'17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash flows from operating activities: | |||||||||||
Net income | |||||||||||
1,937 | 2,421 | 2,515 | 2,212 | 1,581 | 969 | 469 | 8 | -16 | 0 | 0 | 0 |
Adjustments to reconcile net income to cash used in operating activities: | |||||||||||
Interest income | |||||||||||
3,854 | 3,998 | 3,898 | 3,626 | 2,687 | 1,728 | 860 | 78 | 0 | 0 | 0 | 0 |
Unrealized gains (losses) on marketable securities | |||||||||||
95 | 50 | 62 | -22 | -17 | -44 | 9 | 3 | 0 | 0 | 0 | 0 |
Changes in operating assets and liabilities: | |||||||||||
Changes in prepaid expenses and other current assets | |||||||||||
-81 | -83 | -81 | -61 | 102 | 153 | 196 | 208 | 12 | 0 | 0 | 0 |
Changes in accounts payable and accrued expenses | |||||||||||
230 | 58 | -125 | -137 | 153 | 105 | 183 | 195 | 1 | 0 | 0 | 0 |
Changes in income taxes receivable | |||||||||||
35 | -273 | -2 | 142 | -30 | 0 | 0 | 0 | - | - | - | - |
Net cash used by operating activities | |||||||||||
-1,649 | -1,757 | -1,490 | -1,324 | -1,066 | -508 | -413 | -85 | -27 | 0 | 0 | 0 |
Cash flows from investing activities: | |||||||||||
The cash outflow associated with cash deposit in trust account during the period. | |||||||||||
- | 0 | 0 | 0 | - | 0 | 0 | 0 | - | 0 | 0 | 0 |
The cash outflow associated with interest income released from trust account for taxes during the period. | |||||||||||
- | 0 | 0 | -611 | - | 0 | 0 | 0 | - | - | - | - |
Net cash provided by (used in) investing activities | |||||||||||
902 | 1,218 | 933 | 611 | -173,774 | -174,225 | -174,225 | -174,225 | 0 | 0 | 0 | 0 |
Cash flows from financing activities: | |||||||||||
Proceeds from sale of Units in Public Offering | |||||||||||
- | 0 | 0 | 0 | 169,500 | 169,500 | 169,500 | 169,500 | 0 | 0 | 0 | 0 |
Proceeds from Sponsor Loan | |||||||||||
- | - | - | 0 | - | - | - | 1,725 | 0 | 0 | 0 | 0 |
Proceeds from sale of Private Placement Warrants | |||||||||||
- | 0 | 0 | 0 | 4,500 | 4,500 | 4,500 | 4,500 | 0 | 0 | 0 | 0 |
Note payable borrowings | |||||||||||
- | 0 | 0 | 0 | 45 | 45 | 45 | 57 | 12 | 0 | 0 | 0 |
Advance from Sponsor | |||||||||||
- | 0 | 60 | 30 | 74 | 74 | 74 | 74 | 0 | 0 | 0 | 0 |
Payment of offering costs | |||||||||||
- | 0 | 0 | 51 | 364 | 364 | 364 | 317 | 5 | 0 | 0 | 0 |
Net cash provided by financing activities | |||||||||||
500 | -3,850 | -3,940 | -4,341 | 171,161 | 175,161 | 175,161 | 175,539 | 7 | 0 | 0 | 0 |
Increase (decrease) in cash | |||||||||||
- | - | - | -1,054 | - | - | - | 1,229 | -19 | 0 | 0 | 0 |
Cash paid for taxes | |||||||||||
607 | 952 | 772 | 610 | 450 | 0 | 0 | 0 | - | - | - | - |
Supplemental disclosure of non-cash investing and financing activities: | |||||||||||
The amount of deferred offering costs included in accrued offering costs. | |||||||||||
- | - | - | 0 | - | - | - | 0 | - | - | - | 0 |
Deferred underwriting commissions | |||||||||||
- | 0 | 0 | 0 | 7,350 | 7,350 | 7,350 | 7,350 | 0 | 0 | 0 | 0 |
Initial value of common shares subject to possible redemption | |||||||||||
- | 0 | 0 | 0 | 161,033 | 161,033 | 161,033 | 161,033 | 0 | 0 | 0 | 0 |
Change in value of common shares subject to possible redemption | |||||||||||
- | - | - | - | - | - | - | - | - | 0 | 0 | 0 |